Precigen Inc
PGEN
NASDAQ
Biotechnology
$6.10
USD
-0.39 (-6.01%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.33B
Volume 7.9M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
IOVA | Iovance Biotherapeutics Inc | $2.91B | - | +34.5% | - | |
IMNM | Immunome Inc | $2.91B | - | -63.3% | - | |
BEAM | Beam Therapeutics Inc | $2.83B | - | +158.9% | - | |
NRIX | Nurix Therapeutics Inc | $2.69B | - | -58.4% | - | |
RARE | Ultragenyx Pharmaceutical Inc | $2.55B | - | +17.5% | - | |
PGEN | Precigen Inc | $2.52B | - | +1875.0% | - | |
BCRX | BioCryst Pharmaceuticals Inc | $2.46B | - | +68.7% | - | |
KLRA | Kailera Therapeutics Inc | $2.46B | - | - | - | |
CDNA | CareDx Inc | $2.42B | 21.76 | +34.4% | - | |
MLYS | Mineralys Therapeutics Inc | $2.41B | - | - | - | |
COAG | Hemab Therapeutics Holdings Inc | $2.33B | - | - | - |
Top Peer by Growth
Viridian Therapeutics Inc
+23220.3% YoY Revenue
Lowest P/E Ratio
ADMA Biologics Inc
12.97x P/E
Best 1-Year Return
Palvella Therapeutics Inc
+250.7% Return